NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Biomerica Inc (NASDAQ: BMRA)

 
BMRA Technical Analysis
5
As on 4th Feb 2025 BMRA STOCK Price closed @ 0.44 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.88 & Strong Sell for SHORT-TERM with Stoploss of 1.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BMRASTOCK Price

Open 0.47 Change Price %
High 0.47 1 Day -0.03 -6.38
Low 0.43 1 Week -0.16 -26.67
Close 0.44 1 Month 0.15 51.72
Volume 681260 1 Year -0.68 -60.71
52 Week High 1.65 | 52 Week Low 0.27
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 118.65 1.71%
TNXP 0.15 -21.05%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
BHAT 0.04 -20.00%
PONO 1.72 2.38%
TELL 1.00 0.00%
PLUG 1.95 4.84%
LCID 2.93 4.64%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
RELIW 0.06 200.00%
GDEVW 0.05 150.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
OMGA 0.15 -68.75%
SWAGW 0.01 -66.67%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
NLSPW 0.01 -50.00%
 
 
BMRA
Daily Charts
BMRA
Intraday Charts
Whats New @
Bazaartrend
BMRA
Free Analysis
 
BMRA Important Levels Intraday
RESISTANCE0.52
RESISTANCE0.49
RESISTANCE0.48
RESISTANCE0.46
SUPPORT0.42
SUPPORT0.40
SUPPORT0.39
SUPPORT0.36
 
BMRA Forecast February 2025
4th UP Forecast1.44
3rd UP Forecast1.12
2nd UP Forecast0.92
1st UP Forecast0.72
1st DOWN Forecast0.16
2nd DOWN Forecast-0.04
3rd DOWN Forecast-0.24
4th DOWN Forecast-0.56
 
BMRA Weekly Forecast
4th UP Forecast0.73
3rd UP Forecast0.64
2nd UP Forecast0.58
1st UP Forecast0.52
1st DOWN Forecast0.36
2nd DOWN Forecast0.30
3rd DOWN Forecast0.24
4th DOWN Forecast0.15
 
BMRA Forecast2025
4th UP Forecast4.08
3rd UP Forecast2.91
2nd UP Forecast2.19
1st UP Forecast1.47
1st DOWN Forecast-0.59
2nd DOWN Forecast-1.31
3rd DOWN Forecast-2.03
4th DOWN Forecast-3.2
 
 
BMRA Other Details
Segment EQ
Market Capital 55674836.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
BMRA Address
BMRA
 
BMRA Latest News
 
Your Comments and Response on Biomerica Inc
 
BMRA Business Profile
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. Address: 17571 Von Karman Avenue, Irvine, CA, United States, 92614
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service